SOLESENCE, INC.
SOLESENCE, INC. Q3 FY2024 earnings call
November 2, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-11-02
Management highlights
- Thanks to the team, brand partners, supplier partners, and investors. - Q3 was a milestone, with two of the three months achieving record throughput levels, using OEE metrics to focus on increasing uptime and labor efficiency. - Excellent inventory availability led to a significant improvement in on - time in full performance, with over 90% of planned shipments completed within the quarter. - Shipped and open orders at 9/30/2024 were $34 million, about 80% higher than the same period in 2023, and more than a third of that is expected in Q4. - Commercially, APIs offer environmental protection in a safe manner, and Solésence has helped bring finished mineral - based solutions to new markets, with prestige cosmetics consumers demanding more Solésence - enabled products.
Segment performance
In Q3 2024, total revenue was nearly $17 million and net income exceeded $3 million. Year - over - year, the net income went from an 18% loss in Q3 2023 to an 18% net income ($3.1 million) in Q3 2024, a swing of $4.5 million. For the nine - month period of 2024, total revenue was $40 million, which was over $10 million or 36% more than the prior year's nine - month numbers. 2024 revenue is expected to exceed $50 million, and potentially reach the mid - to - upper $50 million range. Gross profit was $13.4 million, 34% of sales, which was $6 million more than the nine - month 2023 gross profit, and the gross profit percentage was up 9 points. The nine - month net income in 2024 was $4.8 million versus a $2.3 million loss in 2023, an improvement of over $7 million.
Guidance
- Expect 2024 revenue to exceed $50 million, potentially reaching the mid - to - upper $50 million range. - See solid customer demand into 2025 and expect growth as operational efficiencies improve. - Q4 revenue is typically lower as a percentage of total revenue than Q2 and Q3, but expect 2024 revenue to exceed $50 million. - Anticipate record Q4 revenue in 2024 and record Q1 revenue in 2025.
Risks
- Decision of customers to cancel purchase orders or supply agreements. - Demand for and acceptance of the company's products. - Changes in development and distribution relationships. - Impact of competitive products and technologies. - Possible disruption in commercial activities due to public health issues, terrorist activity, and armed conflict. - Supply chain risks related to China, although there are alternative non - Chinese sources for materials from China already built into the plan.
Q&A highlights
Q: John Henderson asked about the peak period of orders in 2025.
A: Kevin Cureton said the business is non - seasonal, but there are timeframes like late first quarter to early second quarter for new launches and reorders, with Q4 also having orders and globalization affecting it.
Q: John Henderson asked about potential 40% gross margins.
A: Jess Jankowski said it's possible, depending on production stability and efficiency.
Q: John Henderson asked about the ability to reach $100 million capacity.
A: Jess Jankowski said they have the capacity now and will adjust capacity for different components as needed.
Q: Jim Liberman asked if the company can provide products to a broader range of end users.
A: Kevin Cureton said brands range from prestige to masstige, and they will be selective to ensure unit profit.
Q: Jim Liberman asked about tax loss carry forwards.
A: Jess Jankowski said they are looking at it at state and federal levels, with a large NOL available.
Q: Anonymous analyst asked about growth in 2025 and beyond.
A: Jess Jankowski said 2025 is expected to have double - digit growth, and Q1 can better indicate 2025, Q3 or can indicate 2026.
Q: Anonymous analyst asked about uplisting.
A: Jess Jankowski said it's being discussed, with the Board regularly discussing it and aiming for more liquidity.
Q: John Henderson asked about stock issuance and China tariff risk.
A: Jess Jankowski said all preferred shares have been converted, and Kevin Cureton said there are alternative non - Chinese sources for Chinese - sourced materials.
Q: Anonymous analyst asked about 2025 production and orders.
A: Jess Jankowski said they are expanding capacity, adding staff, and expect improved throughput and operational efficiency, with on - time delivery bringing reorders
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 2, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.